These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

507 related articles for article (PubMed ID: 21270273)

  • 1. Resveratrol improves oxidative stress and protects against diabetic nephropathy through normalization of Mn-SOD dysfunction in AMPK/SIRT1-independent pathway.
    Kitada M; Kume S; Imaizumi N; Koya D
    Diabetes; 2011 Feb; 60(2):634-43. PubMed ID: 21270273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resveratrol prevents renal lipotoxicity and inhibits mesangial cell glucotoxicity in a manner dependent on the AMPK-SIRT1-PGC1α axis in db/db mice.
    Kim MY; Lim JH; Youn HH; Hong YA; Yang KS; Park HS; Chung S; Ko SH; Shin SJ; Choi BS; Kim HW; Kim YS; Lee JH; Chang YS; Park CW
    Diabetologia; 2013 Jan; 56(1):204-17. PubMed ID: 23090186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extracellular Superoxide Dismutase Attenuates Renal Oxidative Stress Through the Activation of Adenosine Monophosphate-Activated Protein Kinase in Diabetic Nephropathy.
    Hong YA; Lim JH; Kim MY; Kim Y; Park HS; Kim HW; Choi BS; Chang YS; Kim HW; Kim TY; Park CW
    Antioxid Redox Signal; 2018 Jun; 28(17):1543-1561. PubMed ID: 29020797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resveratrol increases AdipoR1 and AdipoR2 expression in type 2 diabetic nephropathy.
    Park HS; Lim JH; Kim MY; Kim Y; Hong YA; Choi SR; Chung S; Kim HW; Choi BS; Kim YS; Chang YS; Park CW
    J Transl Med; 2016 Jun; 14(1):176. PubMed ID: 27286657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resveratrol ameliorates hyperglycemia-induced renal tubular oxidative stress damage via modulating the SIRT1/FOXO3a pathway.
    Wang X; Meng L; Zhao L; Wang Z; Liu H; Liu G; Guan G
    Diabetes Res Clin Pract; 2017 Apr; 126():172-181. PubMed ID: 28258028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resveratrol alleviates diabetic cardiomyopathy in rats by improving mitochondrial function through PGC-1α deacetylation.
    Fang WJ; Wang CJ; He Y; Zhou YL; Peng XD; Liu SK
    Acta Pharmacol Sin; 2018 Jan; 39(1):59-73. PubMed ID: 28770830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resveratrol retards progression of diabetic nephropathy through modulations of oxidative stress, proinflammatory cytokines, and AMP-activated protein kinase.
    Chang CC; Chang CY; Wu YT; Huang JP; Yen TH; Hung LM
    J Biomed Sci; 2011 Jun; 18(1):47. PubMed ID: 21699681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of resveratrol and rosuvastatin on experimental diabetic nephropathy in rats.
    Hussein MM; Mahfouz MK
    Biomed Pharmacother; 2016 Aug; 82():685-92. PubMed ID: 27470412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic resveratrol treatment protects pancreatic islets against oxidative stress in db/db mice.
    Lee YE; Kim JW; Lee EM; Ahn YB; Song KH; Yoon KH; Kim HW; Park CW; Li G; Liu Z; Ko SH
    PLoS One; 2012; 7(11):e50412. PubMed ID: 23226280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renoprotective effects of a novel Nox1/4 inhibitor in a mouse model of Type 2 diabetes.
    Sedeek M; Gutsol A; Montezano AC; Burger D; Nguyen Dinh Cat A; Kennedy CR; Burns KD; Cooper ME; Jandeleit-Dahm K; Page P; Szyndralewiez C; Heitz F; Hebert RL; Touyz RM
    Clin Sci (Lond); 2013 Feb; 124(3):191-202. PubMed ID: 22920224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resveratrol ameliorates renal damage by inhibiting oxidative stress-mediated apoptosis of podocytes in diabetic nephropathy.
    Wang F; Li R; Zhao L; Ma S; Qin G
    Eur J Pharmacol; 2020 Oct; 885():173387. PubMed ID: 32710953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fenofibrate improves renal lipotoxicity through activation of AMPK-PGC-1α in db/db mice.
    Hong YA; Lim JH; Kim MY; Kim TW; Kim Y; Yang KS; Park HS; Choi SR; Chung S; Kim HW; Kim HW; Choi BS; Chang YS; Park CW
    PLoS One; 2014; 9(5):e96147. PubMed ID: 24801481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resveratrol protects HUVECs from oxidized-LDL induced oxidative damage by autophagy upregulation via the AMPK/SIRT1 pathway.
    Guo H; Chen Y; Liao L; Wu W
    Cardiovasc Drugs Ther; 2013 Jun; 27(3):189-98. PubMed ID: 23358928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renoprotective effect of a novel selective PPARα modulator K-877 in db/db mice: A role of diacylglycerol-protein kinase C-NAD(P)H oxidase pathway.
    Maki T; Maeda Y; Sonoda N; Makimura H; Kimura S; Maeno S; Takayanagi R; Inoguchi T
    Metabolism; 2017 Jun; 71():33-45. PubMed ID: 28521876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Klotho ameliorates diabetic nephropathy via LKB1-AMPK-PGC1α-mediated renal mitochondrial protection.
    Lee J; Tsogbadrakh B; Yang S; Ryu H; Kang E; Kang M; Kang HG; Ahn C; Oh KH
    Biochem Biophys Res Commun; 2021 Jan; 534():1040-1046. PubMed ID: 33121684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sirt1 resists advanced glycation end products-induced expressions of fibronectin and TGF-β1 by activating the Nrf2/ARE pathway in glomerular mesangial cells.
    Huang K; Huang J; Xie X; Wang S; Chen C; Shen X; Liu P; Huang H
    Free Radic Biol Med; 2013 Dec; 65():528-540. PubMed ID: 23891678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sirt1 is essential for resveratrol enhancement of hypoxia-induced autophagy in the type 2 diabetic nephropathy rat.
    Ma L; Fu R; Duan Z; Lu J; Gao J; Tian L; Lv Z; Chen Z; Han J; Jia L; Wang L
    Pathol Res Pract; 2016 Apr; 212(4):310-8. PubMed ID: 26872534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The protective effect of glycyrrhizic acid on renal tubular epithelial cell injury induced by high glucose.
    Hou S; Zheng F; Li Y; Gao L; Zhang J
    Int J Mol Sci; 2014 Aug; 15(9):15026-43. PubMed ID: 25162824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of diabetes-induced renal oxidative stress by a cantaloupe melon extract/gliadin biopolymers, oxykine, in mice.
    Naito Y; Akagiri S; Uchiyama K; Kokura S; Yoshida N; Hasegawa G; Nakamura N; Ichikawa H; Toyokuni S; Ijichi T; Yoshikawa T
    Biofactors; 2005; 23(2):85-95. PubMed ID: 16179750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renoprotective effects of brown adipose tissue activation in diabetic mice.
    Cai YY; Zhang HB; Fan CX; Zeng YM; Zou SZ; Wu CY; Wang L; Fang S; Li P; Xue YM; Guan MP
    J Diabetes; 2019 Dec; 11(12):958-970. PubMed ID: 31020790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.